Source Post

Stockspot Review iShares Global Healthcare ETF AUD ( ASX : IXJ )

Chris Brycki of Stockspot reviews the iShares Global Healthcare ETF (IXJ), highlighting its benefits for investors seeking diversified global exposure to the healthcare and pharmaceutical sectors. He emphasizes its advantages over individual stock picking due to sector-wide growth drivers like an aging population and innovation, while also noting its liquidity and low costs.

Linked Mentions

Tickers discussed in this post

MRKNeutralLow ConvictionResearch Only

Merck is mentioned as an example of a global healthcare company accessible through the IXJ ETF.

LLYNeutralLow ConvictionResearch Only

Eli Lilly is mentioned as an example of a global healthcare company accessible through the IXJ ETF.

PFENeutralLow ConvictionResearch Only

Pfizer is mentioned as an example of a global healthcare company accessible through the IXJ ETF.

CSLNeutralLow ConvictionResearch Only

CSL is mentioned as a notable Australian success story within the healthcare sector.

RMDNeutralLow ConvictionResearch Only

ResMed is mentioned as a notable Australian success story within the healthcare sector.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.